Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

An HDL Proteomic Score Independently Predicts Incident Atherosclerotic Cardiovascular Disease

An HDL Proteomic Score Independently Predicts Incident Atherosclerotic Cardiovascular Disease

Authors: Melander O, Rohatgi A, Louie JZ, Collier TS, McPhaul MJ, Abbasi F

Citation: JACC Adv. 2025 Jun 25;4(6 Pt 2):101844. doi: 10.1016/j.jacadv.2025.101844.

Specialties:  Cardiology, Endocrinology, Cardiovascular disease

Related content

Publication
Association of MPO Levels With Cardiometabolic Disease Stratified by Atherosclerotic Cardiovascular Risk and Intensity of Therapy in a Workforce Population
Publication
Glycemic Control in Patients with Employer-Sponsored Health Benefits
Audio Podcast
The Cardiometabolic Approach: A Solution to Modern Disease Risk Assessment
Audio Podcast
Instant Insights: Apolipoprotein B
Audio Podcast
From Inflammation to Action: MPO’s Role in Chronic Disease
Test FAQ
CardioIQ® Insulin Resistance Panel with Score
Test FAQ
Cardio IQ® Lipoprotein Fractionation Ion Mobility

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.